In an effort to better address the social aspects of health, CVS Health is launching a network to help connect Aetna's most vulnerable patients to support services in their communities.
Pharmacy
A Veterans Affairs pharmacy in North Charleston, S.C., received the largest amount of opioid pills of all pharmacies nationwide between 2006 and 2012, according to Drug Enforcement Administration data published by The Washington Post.
The FDA has approved Hadlima, a biosimilar to AbbVie's blockbuster rheumatoid arthritis treatment Humira. However, it won't be available in the U.S. until June 2023.
The FDA has approved Pfizer's biosimilar to Rituxan, a treatment for some cancers and autoimmune diseases.
Owens Healthcare, a pharmacy based in Northern California, will sell 12 retail pharmacies to CVS, according to local news station KRCR.
Advertisement
Danville, Pa.-based Geisinger and Rochester, Minn.-based Mayo Clinic supply genetic data to biotechnology company Regeneron to aid its drug discovery efforts, according to The Wall Street Journal.
A new court filing claims that several drugmakers and distributors turned a blind eye to suspicious opioid orders, failing to implement basic measures to halt the shipments, according to The Wall Street Journal.
Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety. Here are nine reported by Becker's Hospital Review in the last month:
Civica Rx, the hospital-owned nonprofit generic drug company, signed a five-year agreement with Hikma Pharmaceuticals to manufacture and supply 14 sterile injectable medications, the two organizations announced July 23.
Amgen and Allergan have launched their biosimilar competitors to two of Roche's top-selling cancer drugs in the U.S., according to PharmaPhorum.